DDOG vs JNJ: Which Is the Better Buy?
Side-by-side comparison of Datadog, Inc. and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Datadog, Inc. · Technology
$104.77
+55.6% upside to fair value
Grade B
High Quality
VS
Johnson & Johnson · Healthcare
$238.46
-11.8% upside to fair value
Med Conviction
Grade C+
QuantHub Verdict
DDOG has more upside to fair value
(+55.6%).
JNJ trades at a lower forward P/E
(20.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DDOG |
JNJ |
| Current Price |
$104.77 |
$238.46 |
| Fair Value Estimate |
$163.01 |
$210.28 |
| Upside to Fair Value |
+55.6%
|
-11.8%
|
| Market Cap |
$37.1B |
$574.7B |
| Forward P/E |
341.2x
|
20.2x
|
| EV / EBITDA |
168.3x
|
13.3x
|
| Price / Sales |
10.8x
|
6.2x
|
| Price / FCF |
37.0x
|
29.4x
|
| Revenue Growth YoY |
+7.6%
|
+6.1%
|
| Gross Margin |
79.9%
|
72.8%
|
| Operating Margin |
-1.3%
|
27.2%
|
| Return on Equity |
3.2%
|
32.87%
|
| Dividend Yield |
0% |
2.18% |
| FCF Yield |
2.7%
|
3.4%
|
| Analyst Consensus |
Strong Buy
|
Moderate Buy
|
Investment Thesis
Datadog, Inc. is a leading cloud-based monitoring and analytics platform specializing in observability and security for cloud-native, microservices, and AI applications. The company benefits from strong product-market fit driven by extensive integrations and a customer-centric approach, reflected in 26% revenue growth to $3.43 billion in fiscal 2025 and 37.4% earnings growth year-over-year. Despi…
Johnson & Johnson is a high-quality healthcare conglomerate focused exclusively on Innovative Medicine and MedTech following the Kenvue spin-off. The company delivered $94.2B in FY2025 revenue with 6% operational growth, generated $19.7B in free cash flow, and guided for $99.5-100.5B in 2026 operational sales (above consensus). However, at $238 the stock trades at a P/S of 6.15x, well above the 5…
Accumulation Zones
| Metric |
DDOG |
JNJ |
| Zone Low |
$122.26 |
$157.71 |
| Zone High |
$138.56 |
$178.74 |
| In Buy Zone? |
Yes
|
No
|